Product image of Bortezomib Reddy Pharma (Bortezomib) supplied by GNH India

Bortezomib Reddy Pharma

Active Ingredient:
Bortezomib
Origin:
EU

Bortezomib Reddy Pharma (Bortezomib)

Bortezomib Reddy Pharma is a pharmaceutical product used for targeted therapy. It is administered intravenously or subcutaneously and is manufactured by Reddy Pharma SAS in the EU.

Manufacturer / TM Owner

Reddy Pharma Sas

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Bortezomib Reddy Pharma is primarily used in the treatment of certain types of cancer, particularly multiple myeloma and mantle cell lymphoma. This medication works by inhibiting proteasomes, which are essential for cell function and survival. It is often prescribed as part of a broader treatment plan to manage these conditions.

Side Effects

  • Common effects of Bortezomib Reddy Pharma may include fatigue, nausea, and peripheral neuropathy. Some individuals may also experience diarrhea, constipation, or a decrease in blood cell counts. These effects can vary in severity and may require monitoring by a healthcare professional.

Precautions & Warnings

  • Bortezomib Reddy Pharma should be handled with care and administered under the supervision of a healthcare professional. It is important to follow the prescribed dosage and administration instructions to minimize the risk of adverse effects. Patients should inform their healthcare provider about any pre-existing conditions or medications they are taking.

Avoid Interactions

  • Bortezomib Reddy Pharma may interact with certain medications, including those that affect liver enzymes or blood cell production. It is advisable to avoid alcohol while using this medication, as it may exacerbate side effects. Always consult a healthcare professional before starting any new medication while on Bortezomib Reddy Pharma.

Frequently Asked Questions

Bortezomib Reddy Pharma is used in the treatment of certain types of cancer, such as multiple myeloma and mantle cell lymphoma.

Bortezomib Reddy Pharma can be administered either intravenously or subcutaneously, depending on the prescription.

Common side effects may include fatigue, nausea, peripheral neuropathy, diarrhea, constipation, and changes in blood cell counts.

Bortezomib Reddy Pharma may interact with certain medications, so it is important to consult a healthcare professional before combining it with other drugs.

Bortezomib Reddy Pharma is manufactured by Reddy Pharma SAS, based in the EU.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Bortezomib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT